Plus   Neg

Myriad Genetics Inc. (MYGN) Broke Out To A New High After Upgrade

Morgan Stanley upgraded its rating on shares of Myriad Genetics Inc. (MYGN) Wednesday morning to "Overweight" from "Equal weight."

Myriad Genetics gapped up at the open Wednesday and rose steadily until mid-morning. Shares finished with a gain of 5.01 at $43.04 on the highest volume of the year. The stock surged past resistance and set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT